Comparison of the efficacy of pharmacological interventions for the prevention of delirium: A systematic review and network meta-analysis

IF 2.1 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Medicina Clinica Pub Date : 2025-04-14 DOI:10.1016/j.medcli.2025.106918
Xiangwu Zhou , Chengguo Yin
{"title":"Comparison of the efficacy of pharmacological interventions for the prevention of delirium: A systematic review and network meta-analysis","authors":"Xiangwu Zhou ,&nbsp;Chengguo Yin","doi":"10.1016/j.medcli.2025.106918","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>In recent years, many pharmacological agents for the prevention of delirium have emerged; however, the efficacy of these agents in preventing delirium remains unclear.</div></div><div><h3>Objective</h3><div>To compare and rank the efficacy of different pharmacological interventions for the prevention of delirium.</div></div><div><h3>Design</h3><div>A systematic review and network meta-analysis.</div></div><div><h3>Methods</h3><div>Relevant randomized controlled trials on drug prevention of delirium were extracted from three electronic databases. A network meta-analysis was then conducted to assess the relative efficacy of drug interventions in preventing delirium. The quality of the data was evaluated using the Cochrane Risk of Bias tool.</div></div><div><h3>Results</h3><div>A total of 80 randomized controlled trials on drug interventions were included in the final analysis. Treatment with dexmedetomidine can prevent delirium.</div></div><div><h3>Conclusion</h3><div>Dexmedetomidine treatment can prevent delirium and reduce patient suffering. Healthcare professionals should be encouraged to use dexmedetomidine for delirium prevention.</div></div>","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":"164 11","pages":"Article 106918"},"PeriodicalIF":2.1000,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicina Clinica","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0025775325001125","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background

In recent years, many pharmacological agents for the prevention of delirium have emerged; however, the efficacy of these agents in preventing delirium remains unclear.

Objective

To compare and rank the efficacy of different pharmacological interventions for the prevention of delirium.

Design

A systematic review and network meta-analysis.

Methods

Relevant randomized controlled trials on drug prevention of delirium were extracted from three electronic databases. A network meta-analysis was then conducted to assess the relative efficacy of drug interventions in preventing delirium. The quality of the data was evaluated using the Cochrane Risk of Bias tool.

Results

A total of 80 randomized controlled trials on drug interventions were included in the final analysis. Treatment with dexmedetomidine can prevent delirium.

Conclusion

Dexmedetomidine treatment can prevent delirium and reduce patient suffering. Healthcare professionals should be encouraged to use dexmedetomidine for delirium prevention.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
比较药物干预对预防谵妄的疗效:系统综述和网络荟萃分析
背景近年来,出现了许多预防谵妄的药物,但这些药物在预防谵妄方面的疗效仍不明确。目的比较不同药物干预对预防谵妄的疗效并对其进行排序。然后进行网络荟萃分析,评估药物干预对预防谵妄的相对疗效。结果 共有80项关于药物干预的随机对照试验被纳入最终分析。结论 使用右美托咪定治疗可预防谵妄。应鼓励医护人员使用右美托咪定预防谵妄。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Medicina Clinica
Medicina Clinica 医学-医学:内科
CiteScore
3.10
自引率
5.10%
发文量
295
审稿时长
22 days
期刊介绍: Medicina Clínica, fundada en 1943, es una publicación quincenal dedicada a la promoción de la investigación y de la práctica clínica entre los especialistas de la medicina interna, así como otras especialidades. Son características fundamentales de esta publicación el rigor científico y metodológico de sus artículos, la actualidad de los temas y, sobre todo, su sentido práctico, buscando siempre que la información sea de la mayor utilidad en la práctica clínica.
期刊最新文献
Agradecimientos Síndrome de Behçet Hemoglobina Belliard, una variante a considerar Efecto del tratamiento anticoagulante oral en la mortalidad de pacientes con insuficiencia cardiaca aguda: Análisis por propensity score. Estudio TAO-ICA Management of anticoagulation and direct oral ancticoagulants in patients with atrial fibrillation treated in Spanish Internal Medicine outpatient clinics
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1